|

Xeloda Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Capecitabine

Pipeline

Phase 2: 1Phase 4: 1

Top Sponsors

  • Rutgers, The State University of New Jersey1
  • H. Lee Moffitt Cancer Center and Research Institute1

Indications

  • Breast Cancer2
  • Cancer2
  • Gastro-Intestinal Intraepithelial Neoplasia1
  • Metastatic Breast Cancer1
  • Breast Neoplasms1

Tampa, Florida1 trial

Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer

Moffitt Cancer Center

Phase 2

Belleville, New Jersey1 trial

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

RWJBarnabas Health Clara Maas Medical Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.